Arcutis Biotherapeutics Stock (NASDAQ: ARQT) stock price, news, charts, stock research, profile.
You can purchase shares of Arcutis Biotherapeutics (NASDAQ:ARQT) through any online brokerage.
Other companies in Arcutis Biotherapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Xencor (NASDAQ:XNCR), Mesoblast (NASDAQ:MESO), Agios Pharmaceuticals (NASDAQ:AGIO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
Arcutis Biotherapeutics has a consensus price target of $25.90.
The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $14.87 last updated December 24, 2024 at 2:50 PM EST.
There are no upcoming dividends for Arcutis Biotherapeutics.
Arcutis Biotherapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Arcutis Biotherapeutics.
Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.